Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect

Background Corticosteroids (CS) with or without adjuvant immunosuppressant agents are standard treatment for pemphigus vulgaris (PV). The efficacy of adjuvant therapies in minimizing steroid-related adverse events (AEs) is unproven. Objectives To utilize data collected in a French investigator-initi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	British journal of dermatology (1951) 2019-08, Vol.182, p.1111-1119
Hauptverfasser:	Chen, D M, Odueyungbo, A, Csinady, E, Gearhart, L, Lehane, P, Cheu, M, Maho‐vaillant, M, Prost‐squarcioni, C, Hebert, V, Houivet, E, Calbo, S, Caillot, F, Golinski, M L, Labeille, B, Picard‐dahan, C, Paul, C, Richard, M A, Bouaziz, J D, Duvert‐lehembre, S, Bernard, P, Caux, F, Alexandre, M, Ingen‐housz‐oro, S, Vabres, P, Delaporte, E, Quereux, G, Dupuy, A, Debarbieux, S, Avenel‐audran, M, d'Incan, M, Bedane, C, Bénéton, N, Jullien, D, Dupin, N, Misery, L, Machet, L, Beylot‐barry, M, Dereure, O, Sassolas, B, Benichou, J, Musette, P, Joly, P
Format:	Artikel
Sprache:	eng
Schlagworte:	Human health and pathology Immunology Life Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!